Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net loss	$ (26,748,113)	$ (27,993,848)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,307,590	2,107,323
Non-cash interest expense	1,973,437	2,967,775
Loss on disposal of equipment	15,988
Change in inventory reserve	1,447,626
Stock compensation expense	727,389	668,374
Gain on extinguishment of debt		(259,353)
Inducement expense related to warrant reprice		7,755,541
Change in fair value of derivative liabilities	(54,623)	122,572
Impairment of right-of-use asset		170,714
Goodwill impairment charge	6,975,520
Changes in operating assets and liabilities
Accounts receivable	386,704	(118,755)
Inventory	(600,186)	(1,891,760)
Other assets	(326,820)	(353,371)
Accounts payable	(519,625)	(667,480)
Accrued compensation and other liabilities	(1,250,476)	(188,322)
Deferred revenue	210,735	(9,808)
Net cash used in operating activities	(16,454,854)	(17,690,398)
Cash flows from investing activities
Purchases of property and equipment	(186,556)	(1,824,765)
Net cash used in investing activities	(186,556)	(1,824,765)
Cash flows from financing activities
Proceeds from issuance of common stock warrants		255,751
Proceeds from issuance of common stock and pre-funded warrants in registered offering, net of selling costs		23,473,962
Proceeds from the exercise of common stock warrants, net of issuance costs		9,094,172
Payment of deferred offering costs		(108,794)
Proceeds from at the market offering, net of issuance costs	989,704
Payments on debt	(8,697,587)	(441,076)
Payments on finance lease obligations	(38,925)	(236,563)
Net cash (used in) provided by financing activities	(7,746,808)	32,037,452
Effects of exchange rates on cash	(1,548,819)	(727,477)
Net (decrease) increase in cash and cash equivalents and restricted cash	(25,937,037)	11,794,812
Cash and cash equivalents and restricted cash at beginning of period	36,632,186	14,107,255
Cash and cash equivalents and restricted cash at end of period	10,695,149	25,902,067
Supplemental disclosure of cash flow information
Cash paid for interest	976,324	886,796
Supplemental disclosures of non-cash investing and financing activities
Right-of-use assets acquired through operating leases		748,294
Inventory transferred to property and equipment		559,230
Property and equipment transferred to inventory	$ 152,243